Ranitidine · RANITIDINE HYDROCHLORIDE 300 mg/1 · Tablet · Oral · Amneal Pharmaceuticals of New York LLC
NDC 53746-0254-01 · 100 TABLET in 1 BOTTLE · ANDA · View full market →
4 companies supply this market — a reasonable cushion if one runs into trouble. The price has jumped 93% in a year, to $0.1968 per unit — sharp rises like this often mean supply is already tightening.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Matched to CMS's representative package for this drug (NDC 64980-0637-03) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 2 quarters since 2024.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amneal Pharmaceuticals of New York LLC | RANITIDINE HYDROCHLORIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals of New York LLC | RANITIDINE HYDROCHLORIDE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Limited | RANITIDINE HYDROCHLORIDE 75 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | RANITIDINE HYDROCHLORIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | RANITIDINE HYDROCHLORIDE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Granules India Ltd | RANITIDINE HYDROCHLORIDE 150 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Ranitidine — NDC 53746-0254-01," retrieved September 3, 2026, https://drugdashboards.com/drug/53746025401.
Free to cite with attribution — see how the data is put together.